Randomized Controlled Trial of Trans-Nasal Tapentadol Vs. Intravenous Tramadol and Diclofenac for Postoperative Pain Management
- 10 March 2025
- journal article
- research article
- Published by Springer Nature in Indian Journal of Surgery
- Vol. 87 (6) , 1076-1080
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The surgical patient of yesterday, today, and tomorrow—a time-trend analysis based on a cohort of 8.7 million surgical patientsInternational Journal of Surgery, 2023
- Ethnic and Gender Diversity Comparison between Surgical Patients and Caring SurgeonsPlastic and Reconstructive Surgery - Global Open, 2020
- Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemicAdvanced Drug Delivery Reviews, 2020
- Factors Determining the Choice of Spinal Versus General Anesthesia in Patients Undergoing Ambulatory Surgery: Results of a Multicenter Observational StudyAdvances in Therapy, 2019
- Assessing pain intensity with the visual analog scale: A plea for uniformityThe Journal of Clinical Pharmacology, 2013
- Postoperative Pain ControlClinics in Colon and Rectal Surgery, 2013
- Tapentadol in Pain ManagementCNS Drugs, 2011
- Tapentadol hydrochloride: A next-generation, centrally acting analgesic with two mechanisms of action in a single moleculeDrugs of Today, 2009
- Clinical Pharmacology of TramadolClinical Pharmacokinetics, 2004
- Pharmacology of diclofenac sodiumThe American Journal of Medicine, 1986